The doctor offered me a choice of a branded or a generic drug.
医生让我选择用有商标的还是没有商标的药物。
Us Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook.
美国的学名药市场：产业趋势，竞争环境，市场机会，未来展望。
Second, generic drugmakers have merged, so a given drug is often made by just one or two companies.
第二，仿制药生产商不断合并，每种药物的生产商通常只有一两个公司。
The new generics could also be a boon to generic drug manufacturers such as Teva, Barr, and Mylan Labs.
新的仿制药同样会使仿制药生产商受益，如梯瓦、巴尔、麦兰医学实验室。
It has expressed concern over generic drug firms increasingly settling patent lawsuits with large MNCs.
表示了对一般药品公司与大型跨国公司之间解决专利诉讼这个问题越来越多的关注。
Injectable leucovorin, a generic drug, is a common part of chemotherapy treatment for colorectal cancer.
注射用亚叶酸钙是一种普通药物，经常做为结直肠癌化疗方案的一种药物。
After a drug loses its patent protection, its price plunges as generic drugmakers fight for market share.
一旦某种药物失去专利保护，仿制药生产商就会一拥而上争夺市场份额，导致价格暴跌。
ARV prices have dropped significantly and procurement systems have improved, as has generic drug availability.
ARV药物的价格已经明显下降，采购体制也得到了改善，生物药品的可获得性也有所改善。
Teva is the world's largest generic drug maker but hasn't focused on private-label branded products in the past.
梯瓦公司是世界上最大的仿制药制造公司，但是过去并没有注意自由品牌的开发。
Suggestion for the improvement of the legalized management of Chinese generic drug is made based on comparison.
通过比较，提出了完善我国仿制药法制化管理的建议。
Developing our own generic drug superstars is one of the ways to vitalize our national pharmaceutical industry.
培养仿制药大品种是振兴民族制药企业的可行途径之一。
GDUFA requires that FDA and human generic drug manufacturers alike must meet certain requirements and commitments.
GDUFA要求FDA和人用仿制药生产商必须符合特定的要求和承诺。
Generic drug exclusivity is a unique form of administrative protection for pharmaceutical products in United States.
仿制药独占制度是美国特有的一种药品行政保护形式。
In 2007, Brazil sidestepped a patent on Merck & Co Inc's AIDS drug Efavirenz to import a cheaper generic drug from India.
2007年，巴西曾绕开了默克公司的抗艾药物依非韦仑的专利，转而从印度进口了一种较为廉价的非专利药物。
This is a fascinating research from WHO that shows the effect of generic drugs on anti-retroviral drug compounds and cocktails.
一个世界卫生组织令人惊喜的研究展现了非专利药对治疗艾滋病的抗逆转录病毒复合药和鸡尾酒药的影响。
The deals behind the FTC crackdown have become increasingly common ever since Congress opened the door for generic drug competition in 1984.
这种被联邦贸易委员会所攻击的交易其实在1984年国会为仿制药生产商参与竞争打开方便之门后就变的越来越普遍了。
Simcere calls Bicun a "first-to-market, branded generic drug." Edaravone has been investigated heavily in Japan for use as a neuroprotectant.
先声称必存为“市场第一，品牌的仿制药。”在日本，对依达拉奉作为一种神经保护剂进行了大量研究。
It is the lead drug candidate for Opko, a Miami start-up company run by Phillip Frost, the billionaire who founded the generic drug company Ivax.
它是Opko候选的主打药物。Opko是一家迈阿密公司，由建立了基因药物公司Ivax的亿万富翁PhillipFrost经营。
First Generic Drug for Domestic Market – following the international market, develop first to file generic products established platform technologies.
国内首仿密切关注国外上市的新制及市场前景，利用释药平台技术进行国内首仿。
The law is based on an agreement negotiated by FDA andrepresentatives of the generic drug industry to address a growing number of regulatorychallenges.
法律是基于FDA和仿制药行业代表的谈判协议的，其中讨论了日益增加的法规挑战。
Generic drug application reviewers focus on bioequivalence data, chemistry and microbiology data, requests for plant inspection, and drug labeling information.
仿制药申请的的评审官着重于生物等效性资料，化学和生物资料，工厂检查的要求和药品标签信息等。
Actually, once a drug becomes generic, the reps cease promoting it because they are all or partly paid on commission and there is no commission for generic drugs.
其实，一旦成为通用的药物，药物代表代表停止促进销售，因为他们都是或部分支付佣金，非专利药品没有佣金。
Regardless of the outcome, the case raises an important legal question: how can a firm like Apotex bring a generic drug to market when others own a perfectly valid patent for it?
不管最后结果如何，该案例引发了一个重大的法律问题：象Apotex这样的仿制药品怎么会闯入别人拥有完全有效专利认可的药品市场呢？
Mylan had said it received patent licenses and the right to market generic versions of all three dosage strengths of the drug under a 2007 patent lawsuit settlement with Glaxo.
Mylan还表示，目前已经获得出售这些药物的专利执照，有权向市场出售。
Mylan had said it received patent licenses and the right to market generic versions of all three dosage strengths of the drug under a 2007 patent lawsuit settlement with Glaxo.
Mylan还表示，目前已经获得出售这些药物的专利执照，有权向市场出售。
应用推荐